• Mutation; HGNC; 11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
  
• Mutation; HGNC; 11998; TP53; Simple; p.Arg181His (c.542G>A); ClinVar=VCV000142320; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
  
• Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
  
• Mutation; HGNC; 11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
  

PubMed=9804556; DOI=10.1126/science.282.5391.1145
Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M.
Embryonic stem cell lines derived from human blastocysts.
Science 282:1145-1147(1998)

PubMed=14745950; DOI=10.1002/dvdy.10431
Carpenter M.K., Rosler E.S., Fisk G.J., Brandenberger R., Ares X., Miura T., Lucero M., Rao M.S.
Properties of four human embryonic stem cell lines maintained in a feeder-free culture system.
Dev. Dyn. 229:243-258(2004)

PubMed=16388305; DOI=10.1038/nbt1177
Ludwig T.E., Levenstein M.E., Jones J.M., Berggren W.T., Mitchen E.R., Frane J.L., Crandall L.J., Daigh C.A., Conard K.R., Piekarczyk M.S., Llanas R.A., Thomson J.A.
Derivation of human embryonic stem cells in defined conditions.
Nat. Biotechnol. 24:185-187(2006)

PubMed=16919167; DOI=10.1186/1741-7007-4-28
Josephson R., Sykes G., Liu Y., Ording C.J., Xu W.-N., Zeng X.-M., Shin S., Loring J.F., Maitra A., Rao M.S., Auerbach J.M.
A molecular scheme for improved characterization of human embryonic stem cell lines.
BMC Biol. 4:28.1-28.13(2006)

PubMed=17570852; DOI=10.1186/gb-2007-8-6-r113
Hirst M., Delaney A., Rogers S.A., Schnerch A., Persaud D.R., O'Connor M.D., Zeng T., Moksa M., Fichter K., Mah D., Go A., Morin R.D., Baross A., Zhao Y.-J., Khattra J., Prabhu A.-L., Pandoh P., McDonald H., Asano J., Dhalla N., Ma K., Lee S., Ally A., Chahal N., Menzies S., Siddiqui A., Holt R., Jones S., Gerhard D.S., Thomson J.A., Eaves C.J., Marra M.A.
LongSAGE profiling of nine human embryonic stem cell lines.
Genome Biol. 8:R113.1-R113.12(2007)

PubMed=17572666; DOI=10.1038/nbt1318
Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P.W., Beighton G., Bello P.A., Benvenisty N., Berry L.S., Bevan S., Blum B., Brooking J., Chen K.G., Choo A.B.H., Churchill G.A., Corbel M., Damjanov I., Draper J.S., Dvorak P., Emanuelsson K., Fleck R.A., Ford A., Gertow K., Gertsenstein M., Gokhale P.J., Hamilton R.S., Hampl A., Healy L.E., Hovatta O., Hyllner J., Imreh M.P., Itskovitz-Eldor J., Jackson J., Johnson J.L., Jones M., Kee K., King B.L., Knowles B.B., Lako M., Lebrin F., Mallon B.S., Manning D., Mayshar Y., McKay R.D.G., Michalska A.E., Mikkola M., Mileikovsky M., Minger S.L., Moore H.D., Mummery C.L., Nagy A., Nakatsuji N., O'Brien C.M., Oh S.K.W., Olsson C., Otonkoski T., Park K.-Y., Passier R., Patel H., Patel M., Pedersen R., Pera M.F., Piekarczyk M.S., Reijo Pera R.A., Reubinoff B.E., Robins A.J., Rossant J., Rugg-Gunn P., Schulz T.C., Semb H., Sherrer E.S., Siemen H., Stacey G.N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T.T., Tuuri T., van den Brink S., Vintersten K., Vuoristo S., Ward D., Weaver T.A., Young L.A., Zhang W.-D.
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.
Nat. Biotechnol. 25:803-816(2007)

PubMed=20641038; DOI=10.1002/stem.471
Gutierrez-Aranda I., Ramos-Mejia V., Bueno C., Munoz-Lopez M., Real P.J., Macia A., Sanchez L., Ligero G., Garcia-Parez J.L., Menendez P.
Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection.
Stem Cells 28:1568-1570(2010)

PubMed=20736931; DOI=10.1038/mt.2010.179
Ramos-Mejia V., Melen G.J., Sanchez L., Gutierrez-Aranda I., Ligero G., Cortes J.L., Real P.J., Bueno C., Menendez P.
Nodal/activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.
Mol. Ther. 18:2173-2181(2010)

PubMed=21295703; DOI=10.1016/j.cell.2010.12.032
Bock C., Kiskinis E., Verstappen G., Gu H., Boulting G.L., Smith Z.D., Ziller M.J., Croft G.F., Amoroso M.W., Oakley D.H., Gnirke A., Eggan K.C., Meissner A.
Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines.
Cell 144:439-452(2011)

PubMed=21983960; DOI=10.1038/nmeth.1699
Phanstiel D.H., Brumbaugh J., Wenger C.D., Tian S., Probasco M.D., Bailey D.J., Swaney D.L., Tervo M.A., Bolin J.M., Ruotti V., Stewart R., Thomson J.A., Coon J.J.
Proteomic and phosphoproteomic comparison of human ES and iPS cells.
Nat. Methods 8:821-827(2011)

PubMed=21936705; DOI=10.1089/scd.2011.0400
Ramos-Mejia V., Fernandez A.F., Ayllon V., Real P.J., Bueno C., Anderson P., Martin F., Fraga M.F., Menendez P.
Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification.
Stem Cells Dev. 21:1549-1558(2012)

PubMed=22514597; DOI=10.1371/journal.pone.0030743
Sandt C., Feraud O., Oudrhiri N., Bonnet M.-L., Meunier M.-C., Valogne Y., Bertrand A., Raphael M., Griscelli F., Turhan A.G., Dumas P., Bennaceur-Griscelli A.
Identification of spectral modifications occurring during reprogramming of somatic cells.
PLoS ONE 7:E30743-E30743(2012)

PubMed=22802639; DOI=10.1073/pnas.1209979109
Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N., Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S.
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells.
Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012)

PubMed=23117585; DOI=10.1016/j.scr.2012.09.002
Mallon B.S., Chenoweth J.G., Johnson K.R., Hamilton R.S., Tesar P.J., Yavatkar A.S., Tyson L.J., Park K., Chen K.G., Fann Y.C., McKay R.D.G.
StemCellDB: the human pluripotent stem cell database at the National Institutes of Health.
Stem Cell Res. 10:57-66(2013)

PubMed=24259714; DOI=10.1073/pnas.1319061110
Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H., Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N., Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J., Yamanaka S.
Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells.
Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013)

PubMed=27293150; DOI=10.1016/j.stemcr.2016.05.006
Salomonis N., Dexheimer P.J., Omberg L., Schroll R., Bush S., Huo J., Schriml L., Ho Sui S., Keddache M., Mayhew C.N., Shanmukhappa S.K., Wells J.M., Daily K., Hubler S., Wang Y.-L., Zambidis E.T., Margolin A.A., Hide W.A., Hatzopoulos A.K., Malik P., Cancelas J.A., Aronow B.J., Lutzko C.
Integrated genomic analysis of diverse induced pluripotent stem cells from the Progenitor Cell Biology Consortium.
Stem Cell Reports 7:110-125(2016)

PubMed=27476965; DOI=10.1016/j.stem.2016.06.019
Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M., Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M., Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A., Yamanaka S., Yoshida Y.
Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity.
Cell Stem Cell 19:341-354(2016)

PubMed=27688775; DOI=10.1155/2016/3826249
Nagaria P.K., Robert C., Park T.S., Huo J.S., Zambidis E.T., Rassool F.V.
High-fidelity reprogrammed human IPSCs have a high efficacy of DNA repair and resemble hESCs in their MYC transcriptional signature.
Stem Cells Int. 2016:3826249.1-3826249.14(2016)

PubMed=28435121; DOI=10.1016/j.jprot.2017.04.017
Shekari F., Nezari H., Larijani M.R., Han C.-L., Baharvand H., Chen Y.-J., Salekdeh G.H.
Proteome analysis of human embryonic stem cells organelles.
J. Proteomics 162:108-118(2017)

PubMed=28445466; DOI=10.1038/nature22312
Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C., Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G., Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A., Eggan K.C.
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.
Nature 545:229-233(2017)

PubMed=28664172; DOI=10.1016/j.dib.2017.05.036
Shekari F., Nezari H., Chen Y.-J., Baharvand H., Salekdeh G.H.
Data for whole and mitochondrial proteome of human embryonic stem cells.
Data Brief 13:371-376(2017)

PubMed=29246576; DOI=10.1016/j.scr.2017.08.004
Domingo-Reines J., Lopez-Ornelas A., Montes R., Romero T., Rodriguez-Llamas J.L., Lara-Rodarte R., Gonzalez-Pozas F., Ayllon V., Menendez P., Velasco I., Ramos-Mejia V.
Hoxa9 and EGFP reporter expression in human embryonic stem cells (hESC) as useful tools for studying human development.
Stem Cell Res. 25:286-290(2017)

PubMed=29861859; DOI=10.18632/oncotarget.25353
Panova A.V., Bogomazova A.N., Lagarkova M.A., Kiselev S.L.
Epigenetic reprogramming by naive conditions establishes an irreversible state of partial X chromosome reactivation in female stem cells.
Oncotarget 9:25136-25147(2018)

PubMed=30388422; DOI=10.1016/j.stem.2018.10.009
Ludwig T.E., Kujak A., Rauti A., Andrzejewski S., Langbehn S., Mayfield J., Fuller J., Yashiro Y., Hara Y., Bhattacharyya A.
20 years of human pluripotent stem cell research: it all started with five lines.
Cell Stem Cell 23:644-648(2018)

PubMed=35805069; DOI=10.3390/cells11131984
Molina-Ruiz F.J., Introna C., Bombau G., Galofre M., Canals J.M.
Standardization of cell culture conditions and routine genomic screening under a quality management system leads to reduced genomic instability in hPSCs.
Cells 11:1984.1-1984.25(2022)